Neuronal differentiation and cell-cycle programs mediate response to BET-bromodomain inhibition in MYC-driven medulloblastomaPratiti Bandopadhayay, James M. Olson, Federica Piccioni et al.|Nature Communications|2019Cited by 60
Integrated genetic and pharmacologic interrogation of rare cancersAndrew L. Hong, Jesse S. Boehm|Nature Communications|2016Cited by 56
Neuronal differentiation and cell-cycle programs mediate response to BET-bromodomain inhibition in MYC-driven medulloblastomaPratiti Bandopadhayay, James M. Olson, Federica Piccioni et al.|RePEc: Research Papers in Economics|2019Cited by 11
Targeting TRIP13 in favorable histology Wilms tumor with nuclear export inhibitors synergizes with doxorubicinKaruna Mittal, Andrew L. Hong|Communications Biology|2024Cited by 9
Comprehensive structure-function analysis reveals gain- and loss-of-function mechanisms impacting oncogenic KRAS activityJason J. Kwon, Andrew J. Aguirre, Sean A. Misek et al.|bioRxiv (Cold Spring Harbor Laboratory)|2024Cited by 9